— Know what they know.
Not Investment Advice

ATRI NASDAQ

Atrion Corporation
1W: +0.0% 1M: +0.3% 3M: +0.4% 1Y: +1.2% 3Y: -31.2% 5Y: -35.9%
$459.92
Last traded 2024-08-30 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies · $809.4M mcap · 2M float · 1.30% daily turnover

Balance Sheet Trends

Total Assets
$261M -1.5% ▼
5Y CAGR: +2.4%
Total Liabilities
$18M -28.7% ▼
5Y CAGR: -2.6%
Shareholders Equity
$243M +1.4% ▲
5Y CAGR: +2.9%
Cash & Investments
$6M -75.8% ▼
5Y CAGR: -38.0%
Total Debt
$240K +0.0% ▲
Net Debt
-$3M +29.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$45M$22M$32M$5M$4M
Short-Term Investments$24M$19M$29M$21M$3M
Cash & ST Investments$69M$42M$61M$26M$6M
Net Receivables$19M$16M$21M$24M$23M
Inventory$42M$50M$51M$66M$82M
Other Current Assets$0$4M$0$4M$3M
Total Current Assets$132M$112M$137M$119M$115M
Property, Plant & Equip.$85M$95M$98M$124M$125M
Goodwill & Intangibles$11M$11M$11M$11M$11M
Long-Term Investments$32M$46M$19M$9M$8M
Other Non-Current Assets$13M$13M$13M-$5M$674K
Total Non-Current Assets$130M$155M$131M$145M$146M
Total Assets$262M$267M$267M$265M$261M
— Liabilities —
Accounts Payable$6M$7M$7M$12M$7M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$11M$14M$13M$18M$13M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$4M$2M$3M$3M$3M
Total Non-Current Liabilities$13M$13M$10M$7M$5M
Total Liabilities$24M$26M$23M$25M$18M
— Equity —
Common Stock$342K$342K$342K$342K$342K
Retained Earnings$318M$338M$357M$378M$382M
Accumulated OCI-$0$0-$0-$0$0
Total Stockholders Equity$238M$240M$244M$240M$243M
Total Liabilities & Equity$262M$267M$267M$265M$261M
— Key Metrics —
Total Debt$0$0$0$0$240K
Net Debt-$45M-$22M-$32M-$5M-$3M
Total Investments$56M$65M$48M$30M$11M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms